abediterol [extracellular region]

Stable Identifier
R-ALL-9618328
Type
ChemicalDrug
Compartment
extracellular region
Locations in the PathwayBrowser
for Species:
Expand all
Literature References
PubMed ID Title Journal Year
28971615 Efficacy, safety, and tolerability of once-daily abediterol in patients with stable, persistent asthma: a Phase II, randomized, 7-day, crossover study

Beier, J, Fuhr, R, Seoane, B, Massana, E, de Miquel, G, Pujol, H, Ruiz, S

Pharmacol Res Perspect 2017
22588259 Pharmacological characterization of abediterol, a novel inhaled β(2)-adrenoceptor agonist with long duration of action and a favorable safety profile in preclinical models

Aparici, M, Gómez-Angelats, M, Vilella, D, Otal, R, Carcasona, C, Viñals, M, Ramos, I, Gavaldà, A, De Alba, J, Gras, J, Cortijo, J, Morcillo, E, Puig, C, Ryder, H, Beleta, J, Miralpeix, M

J. Pharmacol. Exp. Ther. 2012
27439370 Abediterol, a novel long-acting β2-agonist: bronchodilation, safety, tolerability and pharmacokinetic results from a single-dose, dose-ranging, active-comparator study in patients with COPD

Beier, J, Pujol, H, Seoane, B, Jimenez, E, Astbury, C, Massana, E, Ruiz, S, de Miquel, G

BMC Pulm Med 2016
External Reference Information
External Reference
abediterol [Guide to Pharmacology:9326]
Participates
as a member of
Disease
Name Identifier Synonyms
asthma DOID:2841 chronic obstructive asthma with acute exacerbation, chronic obstructive asthma, exercise-induced asthma, chronic obstructive asthma with status asthmaticus, Exercise induced asthma, bronchial hyperreactivity
chronic obstructive pulmonary disease DOID:3083 chronic obstructive airway disease, chronic obstructive lung disease, COLD, COPD
Cross References
Mondo
ChEBI
Cite Us!